aluates Reports

$ 0.0

Automative

Global Soft Tissue Sarcoma Targeted Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-31O16438

Global Soft Tissue Sarcoma Targeted Drugs Market Research Report 2024

BUY CHAPTERS

Global Soft Tissue Sarcoma Targeted Drugs Market Research Report 2025

Code: QYRE-Auto-31O16438

Report

September 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Pfizer Inc

Johnson & Johnson

GSK

Celgene

Bristol–Myers Squibb

BeiGene Ltd

Shenzhen Chipscreen

Monopar Therapeutics

Akeso Biopharma

Johnson & Johnson

Soft Tissue Sarcoma Targeted Drugs Market

The global market for Soft Tissue Sarcoma Targeted Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Soft Tissue Sarcoma Targeted Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Soft Tissue Sarcoma Targeted Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Soft Tissue Sarcoma Targeted Drugs in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Soft Tissue Sarcoma Targeted Drugs include Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene, Shenzhen Chipscreen, Monopar Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Soft Tissue Sarcoma Targeted Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Tissue Sarcoma Targeted Drugs.

The Soft Tissue Sarcoma Targeted Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soft Tissue Sarcoma Targeted Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Soft Tissue Sarcoma Targeted Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Soft Tissue Sarcoma Targeted Drugs Market Report

Report Metric	Details
Report Name	Soft Tissue Sarcoma Targeted Drugs Market
Segment by Type	Local Sarcoma Metastatic Sarcoma Other Sarcoma
Segment by Application	Hospitals Oncology Centers Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene, Shenzhen Chipscreen, Monopar Therapeutics, Akeso Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Tissue Sarcoma Targeted Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Soft Tissue Sarcoma Targeted Drugs Market report?

Ans: The main players in the Soft Tissue Sarcoma Targeted Drugs Market are Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene, Shenzhen Chipscreen, Monopar Therapeutics, Akeso Biopharma

What are the Application segmentation covered in the Soft Tissue Sarcoma Targeted Drugs Market report?

Ans: The Applications covered in the Soft Tissue Sarcoma Targeted Drugs Market report are Hospitals, Oncology Centers, Other

What are the Type segmentation covered in the Soft Tissue Sarcoma Targeted Drugs Market report?

Ans: The Types covered in the Soft Tissue Sarcoma Targeted Drugs Market report are Local Sarcoma, Metastatic Sarcoma, Other Sarcoma

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Local Sarcoma

1.2.3 Metastatic Sarcoma

1.2.4 Other Sarcoma

1.3 Market by Application

1.3.1 Global Soft Tissue Sarcoma Targeted Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Oncology Centers

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Perspective (2020-2031)

2.2 Global Soft Tissue Sarcoma Targeted Drugs Growth Trends by Region

2.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Region (2020-2025)

2.2.3 Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031)

2.3 Soft Tissue Sarcoma Targeted Drugs Market Dynamics

2.3.1 Soft Tissue Sarcoma Targeted Drugs Industry Trends

2.3.2 Soft Tissue Sarcoma Targeted Drugs Market Drivers

2.3.3 Soft Tissue Sarcoma Targeted Drugs Market Challenges

2.3.4 Soft Tissue Sarcoma Targeted Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue

3.1.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue (2020-2025)

3.1.2 Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Soft Tissue Sarcoma Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Soft Tissue Sarcoma Targeted Drugs Revenue

3.4 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio

3.4.1 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024

3.5 Global Key Players of Soft Tissue Sarcoma Targeted Drugs Head office and Area Served

3.6 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application

3.7 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Type

4.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Type (2020-2025)

4.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031)

5 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Application

5.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Application (2020-2025)

5.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)

6.2 North America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)

6.4 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)

7.2 Europe Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)

7.4 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)

8.2 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)

9.2 Latin America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)

9.4 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)

10.2 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Soft Tissue Sarcoma Targeted Drugs Introduction

11.1.4 Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Soft Tissue Sarcoma Targeted Drugs Introduction

11.2.4 Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Introduction

11.3.4 Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 GSK Plc

11.4.1 GSK Plc Company Details

11.4.2 GSK Plc Business Overview

11.4.3 GSK Plc Soft Tissue Sarcoma Targeted Drugs Introduction

11.4.4 GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.4.5 GSK Plc Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Details

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Introduction

11.5.4 Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Celgene

11.6.1 Celgene Company Details

11.6.2 Celgene Business Overview

11.6.3 Celgene Soft Tissue Sarcoma Targeted Drugs Introduction

11.6.4 Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.6.5 Celgene Recent Development

11.7 Bristol Myers Squibb

11.7.1 Bristol Myers Squibb Company Details

11.7.2 Bristol Myers Squibb Business Overview

11.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Introduction

11.7.4 Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.7.5 Bristol Myers Squibb Recent Development

11.8 BeiGene

11.8.1 BeiGene Company Details

11.8.2 BeiGene Business Overview

11.8.3 BeiGene Soft Tissue Sarcoma Targeted Drugs Introduction

11.8.4 BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.8.5 BeiGene Recent Development

11.9 Shenzhen Chipscreen

11.9.1 Shenzhen Chipscreen Company Details

11.9.2 Shenzhen Chipscreen Business Overview

11.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Introduction

11.9.4 Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.9.5 Shenzhen Chipscreen Recent Development

11.10 Monopar Therapeutics

11.10.1 Monopar Therapeutics Company Details

11.10.2 Monopar Therapeutics Business Overview

11.10.3 Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Introduction

11.10.4 Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.10.5 Monopar Therapeutics Recent Development

11.11 Akeso Biopharma

11.11.1 Akeso Biopharma Company Details

11.11.2 Akeso Biopharma Business Overview

11.11.3 Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Introduction

11.11.4 Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

11.11.5 Akeso Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Pfizer Inc

Johnson & Johnson

GSK

Celgene

Bristol–Myers Squibb

BeiGene Ltd

Shenzhen Chipscreen

Monopar Therapeutics

Akeso Biopharma

Johnson & Johnson

List of Tables

Table 1. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Local Sarcoma

Table 3. Key Players of Metastatic Sarcoma

Table 4. Key Players of Other Sarcoma

Table 5. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2025)

Table 9. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2026-2031)

Table 11. Soft Tissue Sarcoma Targeted Drugs Market Trends

Table 12. Soft Tissue Sarcoma Targeted Drugs Market Drivers

Table 13. Soft Tissue Sarcoma Targeted Drugs Market Challenges

Table 14. Soft Tissue Sarcoma Targeted Drugs Market Restraints

Table 15. Global Soft Tissue Sarcoma Targeted Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players (2020-2025)

Table 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)

Table 18. Ranking of Global Top Soft Tissue Sarcoma Targeted Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Headquarters and Area Served

Table 21. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application

Table 22. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Soft Tissue Sarcoma Targeted Drugs Product

Table 50. Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Pfizer Company Details

Table 53. Pfizer Business Overview

Table 54. Pfizer Soft Tissue Sarcoma Targeted Drugs Product

Table 55. Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 56. Pfizer Recent Development

Table 57. Johnson & Johnson Company Details

Table 58. Johnson & Johnson Business Overview

Table 59. Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Product

Table 60. Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 61. Johnson & Johnson Recent Development

Table 62. GSK Plc Company Details

Table 63. GSK Plc Business Overview

Table 64. GSK Plc Soft Tissue Sarcoma Targeted Drugs Product

Table 65. GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 66. GSK Plc Recent Development

Table 67. Teva Pharmaceuticals Company Details

Table 68. Teva Pharmaceuticals Business Overview

Table 69. Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Product

Table 70. Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 71. Teva Pharmaceuticals Recent Development

Table 72. Celgene Company Details

Table 73. Celgene Business Overview

Table 74. Celgene Soft Tissue Sarcoma Targeted Drugs Product

Table 75. Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 76. Celgene Recent Development

Table 77. Bristol Myers Squibb Company Details

Table 78. Bristol Myers Squibb Business Overview

Table 79. Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Product

Table 80. Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 81. Bristol Myers Squibb Recent Development

Table 82. BeiGene Company Details

Table 83. BeiGene Business Overview

Table 84. BeiGene Soft Tissue Sarcoma Targeted Drugs Product

Table 85. BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 86. BeiGene Recent Development

Table 87. Shenzhen Chipscreen Company Details

Table 88. Shenzhen Chipscreen Business Overview

Table 89. Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Product

Table 90. Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 91. Shenzhen Chipscreen Recent Development

Table 92. Monopar Therapeutics Company Details

Table 93. Monopar Therapeutics Business Overview

Table 94. Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Product

Table 95. Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 96. Monopar Therapeutics Recent Development

Table 97. Akeso Biopharma Company Details

Table 98. Akeso Biopharma Business Overview

Table 99. Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Product

Table 100. Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)

Table 101. Akeso Biopharma Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Soft Tissue Sarcoma Targeted Drugs Picture

Figure 2. Global Soft Tissue Sarcoma Targeted Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Type: 2024 VS 2031

Figure 4. Local Sarcoma Features

Figure 5. Metastatic Sarcoma Features

Figure 6. Other Sarcoma Features

Figure 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Oncology Centers Case Studies

Figure 11. Other Case Studies

Figure 12. Soft Tissue Sarcoma Targeted Drugs Report Years Considered

Figure 13. Global Soft Tissue Sarcoma Targeted Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Soft Tissue Sarcoma Targeted Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players in 2024

Figure 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024

Figure 19. North America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)

Figure 21. United States Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)

Figure 25. Germany Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2031)

Figure 33. China Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 51. GSK Plc Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 53. Celgene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 54. Bristol Myers Squibb Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 55. BeiGene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 56. Shenzhen Chipscreen Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 57. Monopar Therapeutics Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 58. Akeso Biopharma Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Soft Tissue Sarcoma Treatment Market Research Report 2024

Global Chemotherapy for Soft Tissue Sarcomas Market Research Report 2025

Sarcoma Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synovial Sarcoma Treatment Market Research Report 2024

Global Pet Cancer Targeted Drug Market Research Report 2024

Global Rhabdomyosarcoma Drug Market Research Report 2024

Global Soft Tissue Biologics Market Research Report 2024

Global Ewing Sarcoma Drugs Market Insights Forecast to 2030

Global Targeted Drugs for NSCLC Market Research Report 2024

Global Targeted Delivery Drugs Market Research Report 2024

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Global Urological Cancer Drugs Market Research Report 2024

Global Targeted Drugs for Multiple Sclerosis Market Research Report 2024

Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Soft Tissue Membrane Market Research Report 2024

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Global Targeted Drugs for Alzheimer s Disease Market Research Report 2024

Global Urological Cancer Therapeutics Drugs Market Research Report 2024

Global Targeted Drug BRAF Inhibitors for NSCLC Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions